Maternal-Fetal Unit, CEDIFETAL, Centro de Diagnostico de Ultrasonido e Imágenes, CEDIUL, Barranquilla, Colombia; the Centers for Disease Control and Prevention, Atlanta, Georgia; Servicio de medicina materno fetal, IPS SOMEFA de Ibagué, Colombia; the Department of Gynecology and Obstetrics, Emory University, Atlanta, Georgia; Instituto Nacional de Salud, Bogotá, Colombia; and the Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas.
Corresponding author: Jennita Reefhuis, PhD, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS E-86, Atlanta, GA 30333; email: [email protected].
Supported by the Colombian Instituto Nacional de Salud and the Centers for Disease Control and Prevention.
Financial Disclosure The authors did not report any potential conflicts of interest.
The authors thank Rita del Pilar Flórez Guevara, Viviana Meza Estrada, Maria del Rosario Ruiz Bonadiez, Francisco Camargo Barros, Rey Cuellar Mandón, Joaquin De La Peña Ospino, Adrian Colmenares-Rodríguez, Dulfary Serna Aristizabal, Rafael Campanelli Medina, and Oscar Roncallo Navas for their contributions to recruitment; Nicolas Castillo-Donado, Eduardo De Nubila-Lizcano, Carlos Bustamante-Zuluaga, and Saray Serrano-Montes for their assistance with the ultrasonography; Israel Diaz Yunez, Ilsy De Vuono De La Torre, and Amanda Barrero-Ortega for their assistance with data abstraction; and Jazmyn Moore for her contribution to developing communication materials.
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention nor the Colombian Instituto Nacional de Salud.
Each author has indicated that he or she has met the journal’s requirements for authorship.